BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15312161)

  • 1. NFATc1 activates the acetylcholinesterase promoter in rat muscle.
    Cohen TV; Randall WR
    J Neurochem; 2004 Sep; 90(5):1059-67. PubMed ID: 15312161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
    Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
    Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
    J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innervation-dependent and fiber type-specific transcriptional regulation of the slow myosin heavy chain 2 promoter in avian skeletal muscle fibers.
    Jiang H; Jordan T; Li J; Li H; DiMario JX
    Dev Dyn; 2004 Oct; 231(2):292-302. PubMed ID: 15366006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart.
    Zhou B; Wu B; Tompkins KL; Boyer KL; Grindley JC; Baldwin HS
    Development; 2005 Mar; 132(5):1137-46. PubMed ID: 15689382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the human brain natriuretic peptide gene by GATA-4.
    He Q; Mendez M; LaPointe MC
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E50-7. PubMed ID: 12067842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
    Cron RQ; Bartz SR; Clausell A; Bort SJ; Klebanoff SJ; Lewis DB
    Clin Immunol; 2000 Mar; 94(3):179-91. PubMed ID: 10692237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
    Mårtensson UE; Bristulf J; Owman C; Olde B
    Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching.
    McCullagh KJ; Calabria E; Pallafacchina G; Ciciliot S; Serrano AL; Argentini C; Kalhovde JM; Lømo T; Schiaffino S
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10590-5. PubMed ID: 15247427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ryanodine receptor 1 in fast skeletal muscle fibers induces a fast-to-slow muscle fiber type transition.
    Jordan T; Jiang H; Li H; DiMario JX
    J Cell Sci; 2004 Dec; 117(Pt 25):6175-83. PubMed ID: 15564379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of fibroblast growth factor receptor 1 gene expression by E2F4 in skeletal muscle cells.
    Parakati R; Dimario JX
    Dev Dyn; 2005 Jan; 232(1):119-30. PubMed ID: 15580623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase.
    Obasanjo-Blackshire K; Mesquita R; Jabr RI; Molkentin JD; Hart SL; Marber MS; Xia Y; Heads RJ
    Cardiovasc Res; 2006 Sep; 71(4):672-83. PubMed ID: 16828070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of acetylcholinesterase by cis-elements within intron I in cultured contracting myotubes.
    Cohen TV; Randall WR
    J Neurochem; 2006 Aug; 98(3):723-34. PubMed ID: 16787423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D1 dopamine receptor activation of NFAT-mediated striatal gene expression.
    Groth RD; Weick JP; Bradley KC; Luoma JI; Aravamudan B; Klug JR; Thomas MJ; Mermelstein PG
    Eur J Neurosci; 2008 Jan; 27(1):31-42. PubMed ID: 18184313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site.
    Hay CW; Sinclair EM; Bermano G; Durward E; Tadayyon M; Docherty K
    J Endocrinol; 2005 Aug; 186(2):353-65. PubMed ID: 16079261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells.
    Du Y; Chen X; Wei X; Bales KR; Berg DT; Paul SM; Farlow MR; Maloney B; Ge YW; Lahiri DK
    Brain Res Mol Brain Res; 2005 May; 136(1-2):177-88. PubMed ID: 15893602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins.
    Rensen SS; Niessen PM; Long X; Doevendans PA; Miano JM; van Eys GJ
    Cardiovasc Res; 2006 Apr; 70(1):136-45. PubMed ID: 16451796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of estrogen receptor alpha expression with decoy oligonucleotide targeted to NFATc1 binding sites in osteoblasts.
    Penolazzi L; Zennaro M; Lambertini E; Tavanti E; Torreggiani E; Gambari R; Piva R
    Mol Pharmacol; 2007 Jun; 71(6):1457-62. PubMed ID: 17389747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.